Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Vidya Kollu MD

Vidya Kollu MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

I am willing to collaborate on research projects.

Research Experience

  • Antibiotic Prophylaxis
  • Carcinoma, Renal Cell
  • Chemotherapy-Induced Febrile Neutropenia
  • Hematopoietic Stem Cell Transplantation
  • Leptotrichia
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Toxoplasmosis, Cerebral
  • Clinical Expertise

  • Cytomegalovirus Infections
  • Epstein-Barr Virus Infections
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Mucositis
  • Multiple Myeloma
  • Educational Expertise

  • Internal Medicine
  • Publications

  • "Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature, (Vidya Kollu, Guido Tricot, Margarida Silverman, Dilek Ince) Case Reports in Infectious Diseases Vidya Kollu, "Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature," Case Reports in Infectious Diseases, vol. 2018, Article ID 9409121, 3 pages, 2018 11/11/2018    
  • Evaluation and identification of protocols for safe and efficacious institutional administration of intravenous immune globulin in hypogammaglobulinemia associated with chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple myeloma. (Doron Feinsilber, Cole McCoy, Parameswaran Hari, Patrick C. Foy, Ravi Narra, Timothy S Fenske, Nirav Niranjan Shah, Laura Christian Michaelis, Vidya Kollu, Katrina Angela Mears, Kristin Osinski, Nancy Froggatt, Ehab L. Atallah, Binod Dhakal ) JCO DOI: 10.1200/JCO.2018.36.30_suppl.250 Journal of Clinical Oncology 36, no. 30_suppl (October 2018) 250-250. 09/25/2018    
  • C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. (Kollu V, Mott SL, Khan R, Farooq U, Jethava Y, Dilek I, Tricot G) Cureus 2018 Jul 08;10(7):e2945 PMID: 30202676 PMCID: PMC6128584 09/12/2018    
  • Clinical factors affecting response to bevacizumab in metastatic colon cancer (Rezwan Islam, MD, FACP,1 Rafiullah Khan, MD,*,2 Asad Ali, MD,3 Vidya Kollu, MD,4 TramAnh Phan, MD,5 Po-Huang Chyou, PhD,5 James K. Burmester, PhD,6 and Muhammad G. Kibriya, MD, PhD7) American Journal of Therapeutics 09/04/2018    
  • Last update: 11/13/2018
    jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70